Press Releases

Clinipace Worldwide, a global digital contract research organization (dCRO), today announced that the company has been listed at No. 36 on FORBES annual ranking of America’s Most Promising Companies -- a list of 100 privately held, high-growth companies with bright futures.

Clinipace Worldwide, a global digital contract research organization (dCRO), today announced significant innovations to its proprietary TEMPO™ eClinical platform.  As a private cloud-based application, TEMPO serves as the technology foundation to all of Clinipace’s clinical development service delivery teams.

Clinipace Worldwide, a global digital contract research organization (dCRO), today announced company executive, Ran Frenkel, RPh, Vice President, International Business Development, will take on additional responsibility as the Managing Director, EMEA.  Country managers in the region will report directly to Frenkel in his new role.

Clinipace Worldwide and Paragon Biomedical, Inc. today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired the privately-held, Irvine, CA-based company and its subsidiaries. The acquisition further expands Clinipace’s therapeutic expertise, site management capabilities, and global footprint.

Clinipace Worldwide has announced that the company has been named to Inc. Magazine’s 31st annual Inc. 500|5000 list. This prestigious list is a compilation of the fastest-growing privately held companies in the country, recognizing their success and potential for the future. 

Clinipace Worldwide announced today the 20th year anniversary of its founding in Europe.

Clinipace Worldwide today announced Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has awarded the company an Oncology Program.  Immediate plans are commencing for two metastatic melanoma studies.

Clinipace Worldwide today announced company executive, Ran Frenkel, RPh, Vice President, International Business Development, was recently elected to the 2012-2013 Investigator Initiated Sponsored Research Association (IISRA) Board of Directors. Frenkel will serve as the organization’s vice president.

Distinguished Physician and Life Science Executive to Lead European-Based Medical and Regulatory Teams While Providing Expert Guidance and Advisory Services to Clients Worldwide

Clinipace Worldwide today announced it has been named the #1 fastest growing private company in the Triangle. This is the second consecutive year Clinipace Worldwide has been named to Triangle Business Journal’s Fast 50 list. The winners were selected and ranked based on revenue growth, percentage rate of growth, and profitability over a three-year period, analyzed by PricewaterhouseCoopers.